Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of Toronto

$141,410.00

Enhancement of nerve regeneration with controlled release of neurotrophic factors

EF 2014-15

Résumé
Nerve injury produces lifelong disability in many patients. Despite the best current surgical methods, clinical results remainsuboptimal. We have previously demonstrated, delivery of growth factors improves functional outcomes in rats with severeperipheral nerve injuries. We now propose using a more clinically-applicable polymer-based drug delivery system toenhance peripheral nerve regeneration. We have developed a prototype of a microsphere-based delivery system whichenhances nerve regeneration by delivering glial cell line derived neurotrophic factor (GDNF), a potent growth factor, toinjured nerves. In Aim 1 we will determine the extent to which the delivery system provides GDNF to nerve tissues. We willthen place the GDNF delivery system around either chronically injured rat nerves (in Aim 2) or into a rat model of clinicallyavailable decellularized nerve grafts (in Aim 3) to provide sustained GDNF delivery. Both experimental paradigms modelclosely the actual clinical realities of human nerve injuries. We will determine the extent to which sustained delivery of GDNFaugments current surgical treatments for peripheral nerve injury using a variety of advanced metrics. Our industrial partnersare eager to incorporate our findings into their existing commercially available processed nerve allograft product.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
446510-2013
Name nom
Borschel, Gregory
Department département
Biomaterials and Biomedical Engineering, Inst. of (IBBME)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
141410
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Enhancement of nerve regeneration with controlled release of neurotrophic factors
Keyword
NSERC
Application summary
Nerve injury produces lifelong disability in many patients. Despite the best current surgical methods, clinical results remainsuboptimal. We have previously demonstrated, delivery of growth factors improves functional outcomes in rats with severeperipheral nerve injuries. We now propose using a more clinically-applicable polymer-based drug delivery system toenhance peripheral nerve regeneration. We have developed a prototype of a microsphere-based delivery system whichenhances nerve regeneration by delivering glial cell line derived neurotrophic factor (GDNF), a potent growth factor, toinjured nerves. In Aim 1 we will determine the extent to which the delivery system provides GDNF to nerve tissues. We willthen place the GDNF delivery system around either chronically injured rat nerves (in Aim 2) or into a rat model of clinicallyavailable decellularized nerve grafts (in Aim 3) to provide sustained GDNF delivery. Both experimental paradigms modelclosely the actual clinical realities of human nerve injuries. We will determine the extent to which sustained delivery of GDNFaugments current surgical treatments for peripheral nerve injury using a variety of advanced metrics. Our industrial partnersare eager to incorporate our findings into their existing commercially available processed nerve allograft product.